Search
forResearch 10 of 1000+
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Safety and Efficacy of Oral administrated Cepharanthine in Non-hospitalized, asymptomatic or mild COVID-19 patients: A Double-blind, Randomized, Placebo-controlled Trial
- Seventeen Cases of Alopecia Areata: Combination of SADBE Topical Immunotherapy with Other Therapies
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- Recovery From Alopecia After COVID-19
- Acceleration of Hair Growth Rate by Topical Liposomal Cepharanthine in Male Androgenetic Alopecia
- Anticancer Effects of Cepharanthine: an Updated Minireview
Community 10 of 1000+
- Second Shed on Oral Min+Fin: Retrograde Thinning Concern
- 3 month Dut .1mg 1.1fin 5mg oral minoxidil plus topical.
- 2 years on 0.5mg dutasteride, 5mg oral minoxidil
- Experience with oral minoxidil/cautionary tale
- M33 (oral ) fin, min and dermastamp
- Dutasteride 2.5mg and oral min 5mg
- Derm wants to start with oral min only?
- Would it be dumb for me to switch to oral minoxidil?
- Topical min 13 months and oral fin 6 months, progress
- Transition from topical to oral minoxidil?
Learn
— no results
Try a deeper search in learn →